Please login to the form below

Not currently logged in
Email:
Password:

Novartis India leader responds to Glivec patent rejection

The head of Novartisí Indian operations has responded to the Glivec cancer drug patent ruling.

The head of Novartisí Indian operations has responded to the Glivec cancer drug patent ruling.

"India is not open for business," said Rajit Shahani in an interview with the Wall Street Journal website, Livemint.com.

In early August 2007, the court issued its decision to uphold the Indian Patents Act and dismissed Novartis' writ petition challenging constitutionality of Section 3(d), regarding incremental innovation.

The Swiss company filed an appeal after its patent application for Glivec was rejected. The drug has been granted patent in approximately 40 countries, including China; but was denied in India in 2006. Novartis challenged the section that it claims does not permit patent to medicines with safety advantages.

"Indian pharma companies and multinational drug makers push for changes in opposite directions on matters such as price control, data protection and definition of patentability," accused Shahani.

He concluded: "Novartis is likely not to appeal the decision. Our actions have advanced this essential debate in India, now itís up to the relevant political leaders and groups to work together to strengthen Indiaís patent law."

24th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 women leaders in UK healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics